However, the indices of tumor cell proliferation inhibition (CD3, CD4, CD4/CD8, IgM, IgA, IgG, and C4) were significantly improved after 6 months of SHD treatment, and CD4/CD8 had improved compared with the control group (Figure 7). The gene discussed is CD79A; the disease is neoplasm.